Stockholders' Equity (Details) - Warrant [Member] - $ / shares |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
| Warrants outstanding, beginning | 284,292 | 284,292 | 284,292 | |
| Weighted average exercise price outstanding, beginning | $ 272.26 | $ 272.26 | $ 272.26 | |
| Weighted average remaining contractual life | 1 year 4 months 28 days | 2 years 4 months 28 days | 1 year 10 months 28 days | 2 years 10 months 28 days |
| No warrant activity | ||||
| Weighted average exercise price, No warrant activity | ||||
| Warrants outstanding, ending | 284,292 | 284,292 | 284,292 | 284,292 |
| Weighted average exercise price outstanding, ending | $ 272.26 | $ 272.26 | $ 272.26 | $ 272.26 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|